Endocrine Society member Patricia Brubaker, PhD, of the University of Toronto, has been recognized by the Royal Society of Canada for her accomplishments in the lab. She will join the prestigious Society as a fellow, as the University of Toronto points out.
Brubaker and her colleague, Endocrine Society member Daniel Drucker, MD, of Mount Sinai Hospital in Toronto, discovered that GLP-2 is an intestinal growth factor, which could be used to treat digestive disorders like Crohn’s and colitis.
Endocrine Society member Holly A. Ingraham, PhD, is the recipient of the FASEB Excellence in Science Lifetime Achievement Award. On April 8, the organization announced the winners of its 2024 Excellence in Science Awards, which highlight outstanding achievements by women in biological sciences who demonstrate not only excellence and innovation in their research fields, but…
The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…
Loading ...
